Translational Development Acquisition Corp.
NASDAQ: TDACW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Financial Services
- Industry
- Shell Companies
- CEO
- Michael Hoffman
- Employees
- 2
- Headquarters
- New York City, United States
- IPO year
- 2025
- Market cap
- $293.7M
- Website
- https://www.translational-development.com
Loading TDACW…
Loading profile data…Frequently asked questions about TDACW
What does Translational Development Acquisition Corp. (TDACW) do?
Translational Development Acquisition Corp., established in 2022 and headquartered in New York, New York, currently possesses no significant business operations. Its primary objective is to finalize a strategic business combination, which could involve a merger, share exchange, asset acquisition, or reorganization, with one or more other entities.
Where does TDACW trade?
Translational Development Acquisition Corp. (TDACW) trades on the NASDAQ Global Market.
What sector is TDACW in?
Translational Development Acquisition Corp. (TDACW) operates in the Financial Services sector, specifically in the Shell Companies industry.
Who is the CEO of Translational Development Acquisition Corp.?
Michael Hoffman is the chief executive officer of Translational Development Acquisition Corp. (TDACW).
Where is Translational Development Acquisition Corp. headquartered?
Translational Development Acquisition Corp. is headquartered in United States.
Does TDACW pay a dividend?
Translational Development Acquisition Corp. (TDACW) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TDACW go public?
Translational Development Acquisition Corp. (TDACW) completed its initial public offering in 2025.